Centerbridge in exclusive talks to buy Magellan Health

June 26 (Reuters) - U.S. healthcare plan and pharmacy benefits manager Magellan Health Inc is in exclusive talks for a possible sale to private equity firm Centerbridge Partners LP, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.

The companies could reach an agreement next month, and should the companies strike a deal, Centerbridge may sell Magellan's assets such as its pharmacy-benefit management business, according to the report

Shares of Magellan, which was valued at $1.6 billion Wednesday morning, rose as much as 7% on the report.

Magellan and Centerbridge did not immediately respond to Reuters requests for comment.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of NASDAQ, Inc.